We investigated the role of copy number variations (CNVs) in Parkinson's disease (PD) using genotyping data from 10,815 patients (2731 early-onset PD, EOPD) and 8901 controls from the COURAGE-PD consortium. CNVs were analyzed using a sliding window genome-wide association and burden approach. No genome-wide significant CNVs were detected in the overall cohort, but a robust deletion spanning exons 2-6 of PRKN was identified in EOPD cases, validated by MLPA, and replicated in the GP2 dataset (23,089 cases, 18,824 controls). CNV burden was significantly enriched in PD-related genes, primarily driven by PRKN, with the strongest effect observed in EOPD. PRKN CNV carriers showed earlier age at onset, confirmed by survival analysis. No association was observed for genome-wide or large CNV burden. Our findings reinforce the pivotal role of PRKN deletions in early-onset PD and highlight the need for high-resolution CNV analysis in large cohorts to uncover additional rare contributors to PD risk.
GrantsPlan Ecophyto (French Ministry of Agriculture) - MRC and UK Medical Research Council EU Joint Program for Neurodegenerative Disease research Global Parkinson's Genetics Program - Michael J. Fox Foundation for Parkinson's Research (MJFF) Fonds National de Recherche (FNR), Luxembourg, as part of the National Centre of Excellence in Research on Parkinson's Disease (NCER-PD) National Centre for Excellence in Research on Parkinson's disease (NCER-PD) - Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services Canadian Consortium on Neurodegeneration in Aging - Estonian Research Council Italian Ministry of Health National Research Foundation of South Africa South African Medical Research Council Stellenbosch University, South Africa South African Medical Research Council Centre for Tuberculosis Research Spanish Ministry of Science and Innovation Michael J. Fox Foundation Agence nationale de recherche (ANR) Michael J. Fox Foundation (USA Genetic Diversity in PD Program: GAP-India) MSA Coalition German Research Council Karolinska Institutet Research Funds - Parkinson's UK Karolinska Institutet Research Fund - Swedish Brain Foundation Swedish Brain Foundation Mrta Lundkvist Foundation National Institutes of Health Swedish Research Council NRF-DST Centre of Excellence for Biomedical Tuberculosis Research